Target intelligence / Profile preview

Eimeria parasite asexual intracellular stages

Molecular classification
Parasite life cycle stage, Apicomplexa
01

Overview

The asexual intracellular stages of Eimeria species, primarily comprising schizogony (merogony), are the developmental phases where the parasite undergoes rapid replication within the host's intestinal epithelial cells (Merck Veterinary Manual, 2023). Following the ingestion of sporulated oocysts, sporozoites invade the gut lining and transform into trophozoites and then schizonts, which release merozoites to continue the infection cycle (Belli et al., 2006). These stages are the primary drivers of the pathology associated with coccidiosis, causing extensive tissue destruction, hemorrhage, and nutrient malabsorption in poultry and livestock (Sharman et al., 2010). Pharmacological control of these stages is achieved through coccidiostats like amprolium, which competitively inhibits thiamine uptake, and ionophores like monensin, which disrupt osmotic balance by transporting cations across parasite membranes (Noack et al., 2019). Because these stages involve complex biological processes rather than a single receptor, they represent a broad therapeutic category rather than a discrete molecular target (Chapman, 2014).

Other names
SchizogonyMerogonyMerozoite stageSchizont stageIntracellular meronts
02

Mechanism of action

Coccidiostats and coccidiocides targeting these stages act through various mechanisms: amprolium acts as a thiamine antagonist; ionophores (e.g., monensin) disrupt ion transport and osmotic balance; quinolones (e.g., decoquinate) inhibit mitochondrial electron transport; and sulfonamides interfere with dihydropteroate synthase in the folic acid pathway (Noack et al., 2019; Merck Veterinary Manual, 2023).

03

Biological functions

Asexual reproductionHost cell invasionIntracellular replicationMetabolic adaptation
04

Disease associations

CoccidiosisInfectionEnteritis
05

Safety considerations

Development of drug resistanceIonophore toxicity in non-target speciesWithdrawal periods for food safetyNarrow therapeutic index
06

Interacting drugs

Amprolium

13 more in the full profile.

07

Biomarkers

Oocysts per gram (OPG)Intestinal lesion scoreParasite-specific DNA (qPCR)Fecal consistency

Beyond the preview

Go deeper on Eimeria parasite asexual intracellular stages.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eimeria parasite asexual intracellular stages.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call